documents: FDA-2008-P-0591-0005
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2008-P-0591-0005 | FDA | FDA-2008-P-0591 | Attachment A - "Clinical Pharmacology and Biophamaceutics Executive Summary" - [Regulus Pharmaceutical Consulting, Inc. - Supplement] | Supporting & Related Material | SUP-Supplement (Supporting and Related Material) | 2010-03-17T04:00:00Z | 2010 | 3 | 2010-03-17T21:43:49Z | 0 | 0 | 0900006480abc01d |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref